Oncology
 |
|
25 january 2023 18:13:57 |
| MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway (BMC Cancer) |
|
Tweet While molecular targeted drugs and other therapies are being developed for many tumors, pancreatic cancer is still considered to be the malignant tumor with the worst prognosis. We started this study to identi... |
| 86 viewsCategory: Oncology |
 Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation (BMC Cancer)A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number (BMC Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
